Ecuador vs India: Confirmed cases of MDR-TB started treatment for MDR-TB
Ecuador
86.0%
in 2012
India
85.0%
in 2012
Ecuador rank
29th
India rank
32nd
Confirmed cases of MDR-TB started treatment for MDR-TB over time
- Ecuador
- India
How they compare
Ecuador currently reports 86.0% against 85.0% in India, a difference of 1.0%.
The two have swapped places 2 times across 5 shared years of data; in 2008 it was Ecuador ahead.
Ecuador ranks 29th and India ranks 32nd of 54 countries.
Across the 2 decades both report, Ecuador averaged higher in 1 and India in 1.
Head to head by decade
| Decade | Ecuador | India | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 212.5% | 65.0% | 147.5% | Ecuador |
| 2010s | 77.0% | 88.3% | 11.3% | India |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher confirmed cases of mdr-tb started treatment for mdr-tb, Ecuador or India?
- Ecuador, at 86.0% against 85.0% in India as of 2012.
- What is the difference in confirmed cases of mdr-tb started treatment for mdr-tb between Ecuador and India?
- 1.0%, with Ecuador ahead.
- How many years of comparable data are there for Ecuador and India?
- 5 years are reported by both, from 2008 to 2012.
- How do Ecuador and India rank globally for confirmed cases of mdr-tb started treatment for mdr-tb?
- Ecuador ranks 29th and India ranks 32nd of 54 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Confirmed cases of MDR-TB started treatment for MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.